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Abstract
Background: Self-administered surveys are an essential methodological tool for health services and knowledge 
translation research, and engaging end-users of the research is critical. However, few documented accounts of the 
efforts invested in recruitment of multiple different stakeholders to one health services research study exist. Here, we 
highlight the challenges of recruiting key stakeholders (policy-makers, clinicians, guideline developers) to a Canadian 
Institutes of Health Research (CIHR) funded health services research (HSR) study aimed to develop an updated and 
refined version of a guideline appraisal tool, the AGREE.
Methods: Using evidence-based methods of recruitment, our goal was to recruit 192 individuals: 80 international 
guideline developers, 80 Canadian clinicians and 32 Canadian policy/decision-makers. We calculated the participation 
rate and the recruitment efficiency.
Results: We mailed 873 invitation letters. Of 838 approached, our participation rate was 29%(240) and recruitment 
efficiency, 19%(156). One policy-maker manager did not allow policy staff to participate in the study.
Conclusions: Based on the results from this study, we suggest that future studies aiming to engage similar 
stakeholders in HSR over sample by at least 5 times to achieve their target sample size and allow for participant 
withdrawals. We need continued efforts to communicate the value of research between researchers and end-users of 
research (policy-makers, clinicians, and other researchers), integration of participatory research strategies, and 
promotion of the value of end-user involvement in research. Future research to understand methods of improving 
recruitment efficiency and engaging key stakeholders in HSR is warranted.
Background
Expectations for well-designed self-administered surveys
are high[1] and results can only be drawn and generalized
based on the quantity, quality and representativeness of
information returned[2]. Therefore, achieving a high par-
ticipation rate is a significant precursor to ensuring the
validity of survey results and minimizing the risk of bias.
Studies show a trend towards decreased participation in
survey research [3]. Thus, we need methods to facilitate
participation. A Cochrane systematic review and meta-
analysis identified several key methods to enhance
response rates to postal questionnaires, including a more
versus less interesting questionnaire, recorded delivery,
and receipt of a monetary incentive[2]. In contrast to
research aimed at improving response rates, however,
there are few documented accounts of the efforts
invested in participant recruitment and the resultant par-
ticipation rates for this investment. The purpose of this
short report is to outline our experiences recruiting prac-
tice guideline developers/researchers, clinicians and pol-
icy-makers to a Canadian Institutes of Health Research
(CIHR) funded health services research (HSR) study. The
object of this study was the Appraisal of Guidelines
Research and Evaluation (AGREE) Instrument, a tool
used to evaluate the quality of practice guidelines (PGs)
reporting [4].
Methods
Identification of target participants and sampling strategy
Following an a-priori sample size calculation for our pri-
mary outcome, our total recruitment target was 192: 80
Canadian clinicians, (oncology, cardiovascular, and criti-
cal care), 80 international guideline developers/research-
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ers, and 32 Canadian policy/decision-makers. Based on
previous specialist response rates to the 2004 Canadian
National Physician survey, we expected to approach 4
physicians for every physician we needed to recruit[5].
We also applied the same oversampling rate to the guide-
line developers/researchers and policy-makers. We iden-
tified potential participants using membership lists from
professional associations, known research/clinician col-
laborations, and professional entities found on the Inter-
net (see Table 1). From this population, we invited a
random sample of clinicians and guideline developers/
researchers, with e-mail addresses, to participate. As we
had fewer candidates, we invited all identified policy-
makers to participate. Informed consent was implied
with the return of completed survey materials. The Ham-
ilton Health Sciences/McMaster University Faculty of
Health Sciences Research Ethics Board approved this
study.
Description of self-administered questionnaire
Our research protocol involved four parts: i) reading a
PG; ii) assessing the PG using either the AGREE Instru-
ment and the Global Rating Scale (Condition 1) or the
Global Rating Scale alone (Condition 2); iii) completing a
survey of perceptions of the usefulness of the instru-
ment(s) from (2); and iv) completion of a short demo-
graphic section. The PGs included 10 documents of 3
clinical areas (4 oncology, 4 cardiovascular, 2 critical
care), and all PGs were 50 pages or less. We randomized
participants to either Condition 1 (134 items total) or
Condition 2 (41 items). For clinicians, we stratified ran-
domization to their corresponding area of expertise (e.g.,
oncologists randomly assigned to condition 1 or condi-
tion 2, and randomized to 1 of 4 oncology PGs). We ran-
domized policy-makers to oncology PGs alone, because
of a smaller pool of participants. Finally, we randomly
allocated developers/researchers to condition and guide-
line. Further details about the primary research protocol
and survey instruments are described elsewhere[6].
From pilot testing, the estimated time to complete all
three parts was no more than two hours for those in Con-
dition 1, and approximately 1.5 hours for Condition 2. We
sent the initial survey by personally addressed e-mail,
which included direct electronic links to the study mate-
rials. Participants had the option of completing the sur-
vey electronically or by paper. In turn, participants could
choose to submit their completed survey materials elec-
tronically via the secure online data portal http://
www.vovici.com, by electronic mail word processing doc-
ument, by post mail or by fax.
To inform our recruitment efforts, we used a systematic
review summarizing evidence-based strategies for
recruitment[2] and a narrative review of key methodolog-
ical steps in survey administration[1]. We incorporated a
modified Dillman approach[7] in our recruitment strate-
gies: we pre-contacted participants via personally
addressed letters on McMaster University letterhead fol-
lowed by a personally addressed e-mail or individual tele-
phone call 10 days later to ascertain their
participation[2,8]. We offered participants a $100 CDN
Table 1: Recruitment data sources.
Participant Type Guideline Developers Clinicians (Oncologists, 
Intensivists, Cardiologists)
Policy/Decision-Makers
Data sources -AGREE partners
-Canadian Medical 
Association Guidelines 
Infobase
-Canadian Partnership Against 
Cancer Corporation
-Conference on Guideline 
Standardization (COGS) 
participants
-Grading of 
Recommendations, 
Assessment, Development, 
and Evaluation (GRADE) 
Working group
-Guidelines International 
Network
Publicly-available lists from 
the websites of the following 
provincial Colleges of 
Physicians and Surgeons:
-Alberta
-British Columbia
Manitoba
-New Brunswick
-Newfoundland and Labrador
-Nova Scotia
-Ontario
-Prince Edward Island
-Canadian Agency for Drugs 
and Technologies in Health
-Cancer Care Ontario 
(Committee to Evaluate 
Drugs, Clinical Program 
Heads, Clinical Council)
-Canadian Pharmacists' 
Association
-Health Canada (Chronic and 
Continuing Care Division, 
Health Products and Food 
Branch, Pharmaceuticals 
Management Strategies, 
Therapeutic Effectiveness and 
Policy Bureau)
-Ontario Health Technology 
Advisory Committee
At the time of our study, the following provinces or territories did not have publicly available physician lists: Saskatchewan, Nunavut, and the 
Northwest Territories. The province of Quebec did not have a list of physicians by specialty (only by physician name). The Yukon Territory 
limited the use of their physician data for informational purposes only.Kho et al. BMC Health Services Research 2010, 10:123
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gift certificate incentive upon completion of study mate-
rials. All participants submitting data received a person-
alized note of thanks. For all participants with
outstanding submissions, we followed up with two
reminder e-mails and/or telephone calls and resent the
complete study package with the second email reminder,
as per our protocol. Our protocol allotted and resourced
for 6.5 months to complete participant recruitment and
data collection.
Outcomes
Using a screening log, we recorded the number of eligible
people and those approached to participate in the study
[ 9 ] .  O f  t h o s e  a p p r o a c h e d ,  w e  r e c o r d e d  t h e  n u m b e r  o f
undeliverable letters, affirmative responses, active
declines, and non-responses. We calculated the participa-
tion rate (number who agreed to participate over the total
number approached)[10], and the recruitment efficiency
(proportion of completed data submissions as a function
of the number of letters sent)[9].
Results
Recruitment and data collection took nearly twice as long
as we anticipated. Table 2 outlines our recruitment
efforts. Between June 7, 2007 and April 2, 2008 we mailed
873 invitation letters to 173 developers, 526 clinicians,
and 174 policy-makers. Thirty five letters were undeliver-
able.
Of 838 pre-contacted, our participation rate was 29%
(240). We received data from 65% (156/240) of the indi-
viduals who agreed to participate, representing a recruit-
ment efficiency of 19% (156/838) of the original sample
invited to participate. Of those who submitted data, 95%
(148) used the online data portal, 7 submitted their data
by electronic mail (word processing document), and 1
submitted their data by post. No respondents returned
their data via fax. Of those participating and submitting
data, we actively monitored each submission for com-
plete data. W e had no missing data for the main study
primary outcomes.
We followed-up with 333 reminder e-mails and 61 tele-
phone calls. Of the reminder e-mails sent, 215 were sec-
ond follow-ups and contained a complete electronic
survey package as per our protocol. Developers/research-
ers were more likely to participate than clinicians and
policy-makers. Of those initially agreeing to participate,
8% (19) actively withdrew from the study and from 26%
(63) we received no data. One policy-maker manager did
not allow the participation of policy staff who already
gave consent, accounting for 5 of 8 policy-maker with-
drawals. Of the 19 withdrawals, 26% (5) occurred before
randomization, 42% (8) were allocated to Condition 1
(the longer condition), and the remaining 32% (6) were
allocated to Condition 2. Of the 63 who did not submit
data, 43% (27) were allocated to Condition 1 and 57% (36)
to Condition 2.
Discussion
Research productivity is dependent on timely receipt,
analysis, and publication of data, which is ultimately
dependent on study sample participation. The validity
and generalizability of survey results are dependent on a
high participation rate and representative sample. We
incorporated the best available evidence to optimize our
participation rates[2] and used previously reported
response rate estimates to guide our recruitment
efforts[5]. While the number of individuals who origi-
nally agreed to participate was 25% higher than our target
sample size, we still missed our target by 17%.
Based on our experiences, and in contrast to previous
research [5], we received 1 person's data for every 5 let-
ters of invitation. Guideline developer/researcher recruit-
ment was highest, probably reflecting their existing
interests in this area. Clinician and policy-maker recruit-
ment was more challenging. Our clinician recruitment
rates were much lower than previous studies, where
recruitment rates for medical oncologists, radiation
oncologists, and cardiologists were 33.0%, 36.9%, and
28.4%, respectively (response rates unavailable for critical
care)[5]. We found similar responses for policy-makers.
As has been found elsewhere[3,11], reasons for our low
recruitment rate might include seasonality, lack of inter-
est, limited time or lack of perceived relevance. Despite
the three-fold difference in the total number of question-
naire items between Condition 1 (n = 134) and Condition
2 (n = 41), there was little impact as a function of study
load; more participants who did not complete data came
from Condition 2, the less demanding study condition. Of
particular interest in our case, we learned that some pol-
icy-makers were actually dissuaded by their superiors
from participating. Although this may be an isolated inci-
dent, this is an interesting finding nonetheless and sug-
gests further fostering the much needed collaboration
between the research and policy/decision-making enti-
ties. Further, lack of anonymity may have dissuaded oth-
ers from participating in the study.
Health services research often relies on the participa-
tion of different stakeholder groups "in the field" to yield
findings that can be useful and relevant to improve the
system. Knowledge translation efforts depend on stake-
holder involvement[12]. We need continued efforts to
communicate the value of research between researchers
and end-users of research (policy-makers, clinicians, and
other researchers), integration of participatory research
strategies[13], and promotion of the value of end-user
involvement in research. Our research team included
perspectives from each of the target groups we sought to
recruit. However, given the breadth of coverage of stake-Kho et al. BMC Health Services Research 2010, 10:123
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holder groups we sought to recruit (perspectives and
geography) it may be that we did not include all "typical"
phenotypes.
Conclusions
Based on the results from this study, we suggest that
future studies aiming to engage similar stakeholders in
HSR over sample by at least 5 times to achieve their target
sample size and allow for participant withdrawals. Con-
tinued use of appropriate evidence-based strategies to
increase survey response rates is important, with a partic-
ular emphasis on highlighting the relevance of the study
to the prospective participants and the importance of
their participation. Further, we suggest ongoing dialogue
about how to best engage end-users. While our recruit-
ment strategies for physicians and policy-makers were
specific to the Canadian health care system, we suggest
that the underlying principles are applicable to any sys-
tematic effort at identifying a population sample. Future
research to understand methods of improving recruit-
Table 2: Recruitment efforts.
Developers Clinicians Policy/Decision-
Makers
Total
Oncology Cardiology Critical Care
Recruitment 
target
80 32 32 16 32 192
Initial 
invitation
Letters sent 173 222 245 59 174 873
Letters 
undeliverable
95 1 71 3 3 5
Total 
approached
164 217 228 58 171 838
Agreed to 
participate
93 52 29 21 45 240
Declined 
participation
71 165 199 37 126 598
Active decline 26 53 75 16 60 230
No response 45 112 124 21 66 368
Participation 
rate
56.7% 24.1% 12.7% 36.2% 26.3% 28.6%
Participant follow-up
Agreed to 
participate
93 52 29 21 45 240
Data received 70 31 14 14 27 156
W i t h d r a w n 451 1 8 1 9
D e f e r r e d 000 2 0 2
No data 
received
19 16 14 4 10 63
Recruitment 
efficiency
42.7% 14.3% 6.1% 24.1% 15.8% 18.6%
Oncologists included medical and radiation oncologists. Declined participation includes active declines, and no responses. Two developers, 
who were not on our recruitment lists, volunteered to participate in the study. One developer, who also held cardiology credentials was 
grouped into cardiologists. One oncologist, who was also a policy-maker, was grouped into policy/decision-makers. Participation rate = 
Agreed to participate/Total approached; Recruitment efficiency = Data received/Total approached.Kho et al. BMC Health Services Research 2010, 10:123
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ment efficiency and engaging key stakeholders in HSR is
warranted.
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